Volume 6, Issue 1 (6-2019)                   vacres 2019, 6(1): 29-32 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Méndez-Samperio P. The Current Status of Bacillus Calmette‐Guérin Vaccine Protective Efficacy. vacres 2019; 6 (1) :29-32
URL: http://vacres.pasteur.ac.ir/article-1-166-en.html
The Current Status of Bacillus Calmette‐Guérin Vaccine Protective Efficacy
Patricia Méndez-Samperio *
Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional
Abstract:   (5355 Views)
The bacillus Calmette‐Guérin (BCG) vaccine against pulmonary tuberculosis (TB) remains with poor protective efficacy. However BCG is the only licensed vaccine against human TB. This review discusses the main research progress in the field of TB vaccine development and will summarize the current status, and main challenges for the development of a safer and more efficient TB vaccine.
Keywords: BCG, global health, clinical trials, tuberculosis, vaccine
Full-Text [PDF 374 kb]   (1429 Downloads)    
Type of Study: Review article | Subject: Vaccine development, efficacy and safety evaluation
Received: 2020/01/16
Add your comments about this article : Your username or Email:
CAPTCHA
Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 All Rights Reserved | Vaccine Research

Designed & Developed by : Yektaweb

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.